Biomed Central Ltd

SHERPA: Unknown

People

  1. Lesokhin
    Lesokhin
  2. Ariyan
    Ariyan
  3. Busam
    Busam
  4. Daniyan
    Daniyan
  5. Funt
    Funt
  6. Hultcrantz
    Hultcrantz
  7. Khalil
    Khalil
  8. Shoushtari
    Shoushtari

Groups

  1. Center for Hematologic Malignancies (7)
  2. Department of Medicine (7)
  3. Hematologic Malignancies, Division of (7)
  4. Myeloma (7)
  5. Hematologic Malignancies Research (6)
  6. Hematology-Oncology Fellows (2)
  7. Melanoma Disease Management Team (2)
  8. Melanoma and Immunotherapeutics Service (2)
  9. Solid Tumor Oncology Division (2)
  10. Adult Leukemia (1)
Search Within
  1. "Myeloma"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
  3. Guidelines (1)
Groups
  1. Center for Hematologic Malignancies (7)
  2. Department of Medicine (7)
  3. Hematologic Malignancies, Division of (7)
  4. Myeloma (7)
  5. Hematologic Malignancies Research (6)
  6. Hematology-Oncology Fellows (2)

More Groups

People
  1. Alexander Lesokhin (3)
  2. Eric Smith (2)
  3. Margaret Callahan (2)
  4. Alexander Shoushtari (1)
  5. Anthony Daniyan (1)
  6. Ariel Bourla (1)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2020 (1)
  4. 2017 (1)
  5. 2016 (1)
  6. 2015 (1)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (5)
  2. BMC Gastroenterology (1)
  3. BMC Medical Research Methodology (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Modelling multiple time-scales with flexible parametric survival models
    Journal Article

    Batyrbekova, N.; Bower, H.; Dickman, P. W.; Ravn Landtblom, A.; Hultcrantz, M.; Szulkin, R.; Lambert, P. C.; Andersson, T. M. L.
    BMC Medical Research Methodology (2022)

    Fulltext@MSK | Save
  • First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid tumors and lymphomas
    Journal Article

    Piha-Paul, S. A.; Geva, R.; Tan, T. J.; Lim, D. W. T.; Hierro, C.; Doi, T.; Rahma, O.; Lesokhin, A.; Luke, J. J.; Otero, J.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma
    Guidelines

    Shah, N.; Aiello, J.; Avigan, D. E.; Berdeja, J. G.; Borrello, I. M.; Chari, A.; Cohen, A. D.; Ganapathi, K.; Gray, L.; Green, D.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • The checkpoint inhibitor TTI-621 (SIRPαFc) stimulates innate and adaptive immune responses in patients with hematologic and solid tumor malignancies
    Meeting Abstract

    Johnson, L.; Ansell, S.; Chen, R.; Flinn, I.; Maris, M.; O'Connor, O.; Lesokhin, A.; Thompson, J.; Akilov, O.; Querfeld, C.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Increased mortality among men aged 50 years old or above with elevated IgA anti-transglutaminase antibodies: NHANES III
    Journal Article

    Rubio-Tapia, A.; Ludvigsson, J. F.; Choung, R. S.; Brantner, T. L.; Rajkumar, S. V.; Landgren, O.; Murray, J. A.
    BMC Gastroenterology (2016)

    Fulltext@MSK | Save
  • Tumor immunology and cancer immunotherapy: Summary of the 2014 SITC primer
    Journal Article

    Page, D. B.; Bourla, A. B.; Daniyan, A.; Naidoo, J.; Smith, E.; Smith, M.; Friedman, C.; Khalil, D. N.; Funt, S.; Shoushtari, A. N.; more...
    Journal for ImmunoTherapy of Cancer (2015)

    Fulltext@MSK | Save
  • Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
    Meeting Abstract

    Callahan, M. K.; Horak, C. E.; Curran, M. A.; Hollman, T.; Schaer, D. A.; Yuan, J.; Lesokhin, A. M.; Kitano, S.; Hong, Q.; Ariyan, C. E.; more...
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save